Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
65,000,000
-
Total 13F shares
-
26,029,473
-
Share change
-
+6,159,246
-
Total reported value
-
$730,115,893
-
Put/Call ratio
-
104%
-
Price per share
-
$28.05
-
Number of holders
-
101
-
Value change
-
+$172,572,667
-
Number of buys
-
67
-
Number of sells
-
31
Institutional Holders of Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) as of Q4 2016
As of 31 Dec 2016 Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) had 101 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 26,029,473 shares of stock of the company.
Largest 10 holders included FMR LLC, BVF INC/IL, DEERFIELD MANAGEMENT CO, WELLINGTON MANAGEMENT GROUP LLP, LORD, ABBETT & CO. LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, BlackRock Fund Advisors, VANGUARD GROUP INC, Opaleye Management Inc., and Cormorant Asset Management, LLC.
This table shows 101 institutional shareholders of the security as of 31 Dec 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.